150 related articles for article (PubMed ID: 22488703)
1. A prospective model of care for breast cancer rehabilitation: bone health and arthralgias.
Winters-Stone KM; Schwartz AL; Hayes SC; Fabian CJ; Campbell KL
Cancer; 2012 Apr; 118(8 Suppl):2288-99. PubMed ID: 22488703
[TBL] [Abstract][Full Text] [Related]
2. A prospective surveillance model for rehabilitation for women with breast cancer.
Stout NL; Binkley JM; Schmitz KH; Andrews K; Hayes SC; Campbell KL; McNeely ML; Soballe PW; Berger AM; Cheville AL; Fabian C; Gerber LH; Harris SR; Johansson K; Pusic AL; Prosnitz RG; Smith RA
Cancer; 2012 Apr; 118(8 Suppl):2191-200. PubMed ID: 22488693
[TBL] [Abstract][Full Text] [Related]
3. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer.
Binkley JM; Harris SR; Levangie PK; Pearl M; Guglielmino J; Kraus V; Rowden D
Cancer; 2012 Apr; 118(8 Suppl):2207-16. PubMed ID: 22488695
[TBL] [Abstract][Full Text] [Related]
4. Low bone density in breast cancer survivors in Korea: prevalence, risk factors and associations with health-related quality of life.
Kim SH; Cho YU; Kim SJ; Lee JE; Kim JH
Eur J Oncol Nurs; 2013 Apr; 17(2):196-203. PubMed ID: 22898655
[TBL] [Abstract][Full Text] [Related]
5. A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues.
McNeely ML; Binkley JM; Pusic AL; Campbell KL; Gabram S; Soballe PW
Cancer; 2012 Apr; 118(8 Suppl):2226-36. PubMed ID: 22488697
[TBL] [Abstract][Full Text] [Related]
6. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
7. Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors.
Clunie GP; Clark A; Mortimer CJ; Stephenson S; Aitken J; Smith C; Sherwin E; Archer TJ
Eur J Surg Oncol; 2009 May; 35(5):475-80. PubMed ID: 18950981
[TBL] [Abstract][Full Text] [Related]
8. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
9. Stakeholder perspectives on dissemination and implementation of a prospective surveillance model of rehabilitation for breast cancer treatment.
Stout NL; Andrews K; Binkley JM; Schmitz KH; Smith RA
Cancer; 2012 Apr; 118(8 Suppl):2331-4. PubMed ID: 22488707
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals.
Harris SR; Schmitz KH; Campbell KL; McNeely ML
Cancer; 2012 Apr; 118(8 Suppl):2312-24. PubMed ID: 22488705
[TBL] [Abstract][Full Text] [Related]
11. Emerging bone health issues in women with breast cancer in Hawai'i.
Carney JF; Davis J
Hawaii Med J; 2007 Jun; 66(6):164-6. PubMed ID: 17621865
[TBL] [Abstract][Full Text] [Related]
12. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
[TBL] [Abstract][Full Text] [Related]
13. Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer.
Swenson KK; Henly SJ; Shapiro AC; Schroeder LM
Clin J Oncol Nurs; 2005 Apr; 9(2):177-84. PubMed ID: 15853161
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of osteoporosis in women with a history of breast carcinoma.
Van Poznak C; Sauter NP
Cancer; 2005 Aug; 104(3):443-56. PubMed ID: 15968687
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.
Wasilewski-Masker K; Kaste SC; Hudson MM; Esiashvili N; Mattano LA; Meacham LR
Pediatrics; 2008 Mar; 121(3):e705-13. PubMed ID: 18310191
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
Chen Z; Maricic M; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS; Bassford TL
Cancer; 2005 Oct; 104(7):1520-30. PubMed ID: 16110508
[TBL] [Abstract][Full Text] [Related]
17. Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care.
Gerber LH; Stout NL; Schmitz KH; Stricker CT
Cancer; 2012 Apr; 118(8 Suppl):2201-6. PubMed ID: 22488694
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
[TBL] [Abstract][Full Text] [Related]
19. Cost considerations regarding the prospective surveillance model for breast cancer survivors.
Cheville AL; Nyman JA; Pruthi S; Basford JR
Cancer; 2012 Apr; 118(8 Suppl):2325-30. PubMed ID: 22488706
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.
Camacho PM; Dayal AS; Diaz JL; Nabhan FA; Agarwal M; Norton JG; Robinson PA; Albain KS
J Clin Oncol; 2008 Nov; 26(33):5380-5. PubMed ID: 18955450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]